Changes in sclerostin, dickkopf-1 and serum markers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with adalimumab.

Susanne Juhl Pedersen, Inge Juul Sørensen, Julia Sidenius Johansen, P. Garnero, A.G. Loft, J. Skjødt, Gorm Milan Thamsborg, K. Asmussen, E. Kluger, J. Nørregaard, T.G. Christensen, Mikkel Østergaard

    OriginalsprogEngelsk
    TidsskriftArthritis & Rheumatism
    Vol/bind64
    Udgave nummer10 suppl.
    Sider (fra-til)S253
    Antal sider1
    ISSN0004-3591
    StatusUdgivet - 2012

    Citationsformater